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1 Abstract 
 
In natural environments microorganisms are constantly exposed to a great diversity of 
viruses and other invasive genetic elements. Consequently, microbes have evolved 
various defense strategies in order to prevent viral attack and invasion of foreign DNA, 
respectively. Clustered regularly interspaced short palindromic repeats (in short: 
CRISPR) characterize one of those defense mechanisms and are found in many 
bacterial and most archaeal genomes. CRISPR/Cas systems confer acquired resistance 
against viruses and plasmids by specifically targeting invasive nucleic acids via 
sequence complementarity between small spacer-derived CRISPR RNAs (crRNAs) and 
so called protospacer sequence of the invading (targeted) nucleic acids. Conversely, 
viruses can find a way to escape CRISPR/Cas resistance by acquisition of mutations 
within their protospacer sequence. Interestingly, not all protospacer mutations lead to 
viral escape. So far the impact of protospacer mutations on CRISPR/Cas-mediated 
interference has mainly been studied in bacterial CRISPR/Cas systems. To learn more 
about the requirements of crRNA-protospacer interaction during CRISPR/Cas-mediated 
interference in Archaea, the hyperthermophilic archaeon Sulfolobus solfataricus and 
its virus SSV1 were used as a model system in this study. Various protospacer mutants 
of the recombinant SSV1 virus were tested in transfection experiments. The 
engineered mutants carried increasing numbers of mutations at the two different ends 
of the protospacer sequence, i.e. six up to 18 consecutive mutations at both ends, 
respectively. The S. solfataricus CRISPR/Cas system conferred almost 100 % immunity 
against the recombinant virus containing six mutations at the “down”-end of the 
protospacer, i.e. at the 3’ end with respect to transcription of the spacer RNA. In 
contrast, viral resistance was severely reduced (by 75 %) when six mutations were 
introduced at the other end (“up”-end) of the protospacer. Still 50 % viral resistance 
was observed when 15 mutations were present at the protospacer “down”-end. Only 
18 mutations at the “down”-end of the protospacer led to almost 100 % viral escape. 
Similar to observations recently made in E. coli, the CRISPR/Cas system was 
significantly more tolerant towards mutations present at the “down”-end of the 
protospacer than at the other end, suggesting that CRISPR/Cas interference in S. 
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solfataricus might be initiated by the recognition of a short sequence at the “up”-end 
of the protospacer. In contrast to the bacterial system however, the required base 
complementarity between the target sequence and crRNA during CRISPR/Cas 
interference seemed to be very low. This might indicate an adaptation to fast evolving 
target sequences, thus providing the host organism with a more flexible recognition of 
related invading elements. 
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2 Introduction 
 
2.1 From the very beginnings of microbiology to the evolutionary tree of life 
 
Even though microorganisms are the smallest form of life, they play central roles in 
many geochemical processes and are known to be major drivers of nutrient recycling 
and degradation of organic matter. The study of microorganisms does not only help to 
understand cellular processes but deals also with many important issues in medicine, 
agriculture and industry (e.g. production of antibiotics and human proteins). Although 
microorganisms are the most abundant entities on earth, microbial cells have not been 
discovered until the invention of the microscope. In 1676 Antoni van Leeuwenhoeck 
recognized microorganisms in a simple microscrope for the first time. Nevertheless 
further progress was only made in the mid- to late nineteenth century primarily driven 
by Louis Pasteur and Robert Koch. Pasteur’s work enabled the development of 
sterilization methods not only for applications in microbiological research but also for 
the purpose of food preservation (see Madigan and Brock 2009). Robert Koch was the 
first to prove the theory that specific microorganisms are linked to the occurrence of 
specific diseases. Besides, he was able to grow organisms in pure culture by the usage 
of solid media (Madigan and Brock 2009). The elucidation of the genetic code by James 
D. Watson and Francis Crick represents another landmark in microbiology (Watson and 
Crick 1953). In the following years the field of molecular microbiology developed. New 
technologies like nucleic acid sequencing techniques and polymerase chain reaction 
discovered by Kary B. Mullis (Mullis and Faloona 1987) revolutionized microbiology 
and introduced molecular phylogeny (Madigan and Brock 2009). This method tries to 
resolve evolutionary relationships among organisms by the comparison of homologous 
genes and led to the discovery of a new domain of life named the Archaea (formerly 
Archaebacteria) by Carl Woese (Woese and Fox 1977). By using rRNA-based (ribosomal 
RNA) phylogenetic analysis Carl Woese identified the three domains of life: Eukarya, 
Bacteria and Archaea (Woese and Fox 1977; Woese et al., 1990). Due to this finding all 
cellular organisms known to date can be divided into the three domains. The 
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combination of advanced molecular technologies and the recognition of phylogenetic 
relationships enabled the identification of microorganisms without the need for 
cultivation and revealed an enormous microbial diversity in all environments on Earth. 
These insights also gave rise to a new subdiscipline of microbiology, the microbial 
ecology, making us aware of the substantial impact that microorganisms have on the 
functioning of ecosystems. 
 
2.2 Archaea-the third domain of life 
 
2.2.1 Phylogeny of Archaea 
Considering the phylogenetic tree of life, it seems that two main lineages diverged 
from a last common ancestor suggesting that all cellular organisms can be traced back 
to one common origin (Woese et al., 1990). One of those two lineages includes the 
domain of Bacteria whereas the second main lineage most likely split again to yield the 
two domains: Eukarya and Archaea.  
Even though Archaea are often associated with extreme environments continuously 
increasing sequence information of uncultured organisms indicate their widespread 
occurrence both in extreme and moderate habitats. Based on today’s state of 
knowledge Archaea can be divided into at least five major phyla: the Crenarchaeota, 
the Euryarchaeota, the Korarchaeota, the Nanoarchaeota and the Thaumarchaeota. 
The hypothesis of the existence of the more recently discovered archaeal phylum 
Thaumarchaeota (Brochier-Armanet et al., 2008) could eventually be supported with 
genome sequencing of the ammonium-oxidizing archaea Nitrosopumilus maritimus 
and Nitrososphaera gargensis (Spang et al., 2010). The Crenarchaeota mainly comprise 
hyperthermophilic organisms often found in terrestrial hot springs and hydrothermal 
vents as for example the model organism Sulfolobus solfataricus (Zillig et al., 1980). 
The Euryarchaeota are quite diverse and include thermophilic, halophilic as well as 
methanogenic organisms. Korarchaeota and Nanoarchaeota belong to two more phyla 
that have been proposed. So far the Nanoarchaeota comprise only one cultured 
representative, the hyperthermophilic Nanoarchaeum equitans (Huber et al., 2002). 
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Beside the enrichment culture of an organism representing a member of the 
Korarchaeota (Elkins et al., 2008) no cultivated member of this group is known so far.  
2.2.2 Major archaeal characteristics-What separates Archaea from Bacteria and 
Eukarya? 
Similar to Bacteria, members of Archaea predominantly consist of single cells that do 
not contain a nucleus or other cell compartments which are characteristic of 
eukaryotic cells. Unlike eukaryotic DNA which is present in linear form within the 
nucleus, the DNA of Archaea and Bacteria is predominantly circular. Both, archaeal and 
bacterial genes are arranged in clusters or operons. Genes of Archaea involved in 
diverse metabolic pathways often reveal greater similarity to those of Bacteria, which 
might reflect the need for similar metabolic capabilities of organisms inhabiting the 
same habitat. However, DNA packaging and information processing (including genes 
and mechanisms involved in replication, transcription and translation) resemble those 
of Eukarya indicating that Archaea are probably more closely related to Eukarya than 
to Bacteria (Forterre et al., 2002).  
The composition of the archaeal cytoplasmatic membrane differs from both Bacteria 
and Eukarya. While bacterial and eukaryotic lipids are esters of fatty acids and glycerol, 
lipids of Archaea contain phytanyl or biphytanyl chains that are linked to glycerol by an 
ether bond (De Rosa et al., 1986). Beside the cytoplasmatic membrane, the 
composition of the archaeal cell wall differs from that of Bacteria as they lack murein 
which is present in the cell wall of most Bacteria. Archaea exhibit a great diversity of 
cell wall compounds including proteins, polysaccharides or pseudomurein, a 
polysaccharide that is very similar to peptidoglycan (Kandler and Konig 1998).  
 
 
2.3 Viruses 
 
2.3.1 General properties of viruses 
Viruses do not carry out independent metabolic activity and thus are often not 
considered as living organisms. Nonetheless, they contain nucleic acid primarily 
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encoding for genes that are essential for successful propagation. Viruses are 
dependent on the infection of cellular organisms providing energy and enzymatic 
“equipment” needed for transcribing and replicating the viral genome. Once several 
copies of the virus genome as well as virus-derived proteins have been produced, the 
replicated genomes are packed into protein coats which finally lead to the formation 
of virions. These are released in order to infect new host cells. Viruses have the ability 
to infect members of all three domains of life whereas a specific virus is typically 
restricted to infect only a small group of closely related organisms. Contrary to cellular 
organisms, viruses use DNA, RNA or even both as genetic material that can be either 
single- or double-stranded. They are very diverse in terms of size and shape whereas 
their genomes are generally smaller than those of cellular organisms. With respect to 
their life cycle viruses can either be virulent or temperate. Virulent means that host 
cells are lysed upon propagation of the virus. Temperate viruses can enter the 
lysogenic pathway in which their genome integrates into the host genome and is 
passed as a so called prophage from one generation to the next. Dependent on host 
performance and environmental conditions, lysogenic viruses can become lytic finally 
leading to host destruction. Even though all viral infections exert stress on their host 
cells to various extents, some of them turn out to be even advantageous and the 
relationship between virus and host might better be described as mutualistic 
(Roossinck 2011).  
2.3.2 Ecological and evolutionary impact 
Viral numbers significantly exceed the abundance of cellular organisms while their 
numbers vary strongly between environments. Various observations have indicated 
the importance of viruses on the functioning and dynamic of diverse ecosystems. For 
example the release of nutrient matter driven by viral induced cell lysis can have great 
impact on microbial food webs and biogeochemical cycles (Weinbauer 2004). Fast 
spreading of viruses and phages in dominant populations are even considered as 
driving force to prevent low abundant species from being outcompeted known as 
‘killing the winner’ hypothesis and by this, might help to sustain high species richness 
(Winter et al., 2010). Additionally, viruses substantially contribute to horizontal gene 
transfer between prokaryotic cells. Virus-mediated gene transfer called transduction 
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means that parts of the host chromosome are accidentally packed inside the mature 
virion and are subsequently transferred into another organism after infection. When 
recombination with the host chromosome occurs, the foreign DNA is integrated into 
the host genome (Madigan and Brock 2009). Rapidly increasing information on whole-
genome sequences revealed the importance of virus-mediated gene transfer and 
raised the hypothesis that viruses exhibit important drivers for the evolutionary 
change of prokaryotic organisms (Weinbauer and Rassoulzadegan 2004). 
2.3.3 Archaeal viruses 
Even though Archaea are widely distributed on Earth, their associated viruses have 
mainly been studied in extreme hydrothermal and hypersaline habitats. All archaeal 
viruses known so far have dsDNA genomes but are highly diverse in terms of their 
morphologies. In contrast to viruses of the phylum Euryarchaeota which 
predominantly resemble the common non-enveloped head-tail morphotype of 
bacteriophages, viruses infecting Crenarchaeota exhibit very diverse and even unique 
morphologies. Those include for example spherical, rod-shaped, bottle-shaped, 
spindle-shaped and filamentous structures (Prangishvili et al., 2006). The majority of 
archaeal viruses that have been isolated from acidothermophilic environments seem 
to be non-lytic and rather persist stably in the host cell by multiplying and releasing 
virus particles continuously. 
 
 
2.4 The CRISPR/Cas system - A newly discovererd viral defence mechanism in 
bacteria and archaea 
 
To our knowledge viruses present the most abundant entities on earth, whose attacks 
microorganisms are facing continuously. Considering this, defence strategies against 
virus infections being often detrimental to their host seem to be crucial to assure 
efficient proliferation of bacterial and archaeal species, respectively. The discovery of 
the so-called CRISPR mechanism was an important progress in this respect and 
describes the acquisition of phage resistance in both bacteria and archaea. CRISPR is 
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the abbreviation for clustered regularly interspaced short palindromic repeats and 
designates an array of highly similar short direct repeats that are separated by non-
repetitive spacer sequences widely spread in microbial genomes.  
 
2.4.1 The history of CRISPR is comparatively short  
CRISPR-research represents a relatively young field in microbiology. Even though the 
existence of a CRISPR sequence was first described in 1987 (Ishino et al., 1987), its 
function was only studied very recently. Increasing genome information together with 
computational analysis revealed that CRISPR sequences are widely distributed in 
bacterial and archaeal genomes indicating that CRISPR-arrays might provide an 
important biological function (Mojica et al., 2000). Findings of spacer sequences 
resembling sections of various phage and plasmid DNA (Bolotin et al., 2005; Mojica et 
al., 2005; Pourcel et al., 2005) eventually raised the hypothesis that CRISPR loci might 
be involved in acquired immunity against invasive elements such as viruses and 
plasmids. Moreover, it was suspected that the underlying mechanism might resemble 
the RNA interference system in eukaryotes (Makarova et al., 2006). Rodolphe 
Barrangou and co-workers were able to show experimentally that the acquisition of a 
new phage-derived spacer upon virus infection indeed confers resistance against the 
virus, thereby supporting initial hypothesis about CRISPR-based acquired viral 
resistance (Barrangou et al., 2007). Whereas the in vivo activity of CRISPR-mediated 
immune response could already be demonstrated in various studies for bacteria 
(Brouns et al., 2008; Marraffini and Sontheimer 2008; Garneau et al., 2010), Manica et 
al (from our laboratory) have only recently been able to show in vivo activity in 
archaea for the first time (Manica et al., 2011). As their work served as the basis for 
this diploma thesis the most important findings of this study as well as some 
background information are described in section 2.5.2. 
 
2.4.2 CRISPR-array composition 
The characteristic CRISPR-array exhibits a leader sequence followed by multiple 
identical or nearly identical direct repeats interspersed with non-repetitive spacer 
sequences ranging from about 26-72 bp’s in seize. The direct repeats are 28-40 bp’s in 
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length. The number of spacer-repeat units can vary strongly from one CRISPR-locus to 
another. Even though the repeat sequences are highly similar within the same CRISPR-
locus, they can vary between distinct loci within one organism. The spacer sequences 
are highly variable but exhibit similar lengths within the same CRISPR-locus. 
Considering the huge numbers of viruses found on earth, the fact that only a small 
portion of spacers match extrachromosomal sequences from phages or plasmids (Shah 
et al., 2009) currently represented in genome databases, is hardly surprising. CRISPR-
loci can occur multiplicate in archaeal as well as bacterial genomes, whereas they 
often differ in both repeat sequence and associated cas genes The presence of 
conserved clusters of cas (CRISPR-associated) genes that are often found in close 
proximity to the CRISPR region (Jansen et al., 2002) constitutes another conserved 
feature within the highly diverse CRISPR systems. Those protein clusters again can be 
extremely divergent between both distinct species and different CRISPR-loci in one 
species, while certain cas gene clusters might be linked to certain types of repeat 
sequences (Kunin et al., 2007). Based on multiple sequence alignments and 
computational analysis Haft and co-workers proposed eight Cas subtypes (Haft et al., 
2005) of which only two (Cas1 and Cas2) out of 45 identified cas gene families (Haft et 
al., 2005) are present in all Cas subtypes. Besides, a ninth subtype called CRISPR RAMP 
(repeat associated mysterious proteins) module usually associated with other Cas 
subtypes has been identified (Haft et al., 2005; Makarova et al., 2006; van der Oost et 
al., 2009). However, growing genomic data sets as well as advanced computational 
analyses continue to reveal previously unknown relationships between CRISPR/Cas 
systems and Cas proteins. Hence, Makarova et al. recently proposed an updated 
classification dividing the CRISPR/Cas systems into three major types (Cas1 and Cas2 is 
found in all three types) each of which can be further classified into system subtypes 
(Makarova et al., 2011). Cas proteins that belong to the so-called RAMP superfamily, 
which can further be split into three major groups (Cas5, Cas6 and Cas7) are found in 
both type I and III systems (Makarova et al., 2011). Several Cas proteins were predicted 
to have nuclease, helicase, integrase or polymerase property, additionally indicating 
that they are linked to processes of CRISPR related immune response (Haft et al., 2005; 
Makarova et al., 2006). Even though the crucial biological role of many Cas proteins 
remain to be resolved some of their functions could already be supported 
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experimentally (Al-Attar et al., 2011). Interestingly, the same CRISPR-locus referring to 
repeat sequence and associated cas gene cluster can be present in different even 
distantly related species implying that CRISPR-loci frequently spread by horizontal gene 
transfer events during microbial evolution (Godde and Bickerton 2006). 
 
2.4.3 The CRISPR/Cas mechanism 
The CRISPR/Cas system can be divided into three main stages (van der Oost et al., 
2009): a) CRISPR-adaptation relating to the incorporation of a new spacer sequence 
within the CRISPR-locus, b) CRISPR-expression that involves transcription of the repeat-
spacer array known as pre-crRNA that is followed by further processing into smaller 
RNA stretches (crRNAs), c) CRISPR-interference meaning the recognition/binding of 
invading nucleic acid molecules and their subsequent degradation. Figure 1 depicts a 
simplified model for the CRISPR/Cas mechanism. 
 
 
 
Figure 1: Simplified model for CRISPR/Cas mechanism (Sorek et al., 2008). The repeat-spacer array is 
transcribed as a long precursor CRISPR-mRNA (pre-crRNA) that is subsequently processed by Cas 
proteins to obtain small CRISPR RNAs (sRNAs), each of which correspond to a single spacer. A complex of 
CRISPR sRNA and Cas proteins binds invading DNA or RNA molecules, respectively via base pairing 
eventually resulting in their degradation. This process is supposed to be mediated by CRISPR-associated 
proteins and is known as CRISPR interference. Source: Review, (Sorek et al., 2008). 
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a) CRISPR-adaptation 
Experimental studies on Streptococcus thermophilus demonstrated that viral infection 
triggered the integration of new phage-derived spacers, in turn conferring resistence 
to the organism previously challenged by the virus (Barrangou et al., 2007). The 
acquisition of novel spacers observed so far appeared to happen at the very beginning 
of the repeat-spacer sequence (Pourcel et al., 2005; Barrangou et al., 2007; Deveau et 
al., 2008) consistent with observations of various strains of Streptococcus thermophilus 
exhibiting greater spacer variability at the leader end (Horvath et al., 2008). Beside the 
addition of new spacers, spacer loss has also been reported to happen within CRISPR-
loci indicating the system’s potential to actively respond to rapidly changing viral 
pressure, thus creating highly variable CRISPR regions (Tyson and Banfield 2008). 
Despite its essential role regarding CRISPR/Cas activity, the process of both spacer 
selection and acquisition is barely understood so far. The presence of conserved 
nucleotide motifs flanking protospacer sequences termed PAMs (protospacer adjacent 
motif) (Mojica et al., 2009) led to the hypothesis that PAMs might contribute to spacer 
recognition and uptake processes. Nevertheless, the existence of so called PAMs as 
well as their actual function is highly speculative and requires additional experimental 
support. 
b) CRISPR-expression 
Transcription of the repeat-spacer array allows the system to access the spacer-
encoded information whereas initially a long precursor CRISPR-mRNA (pre-crRNA) is 
transcribed from a promoter that most probably lies within the leader sequence (Hale 
et al., 2009; Lillestol et al., 2009). The full-length pre-crRNA is subsequently cleaved 
within the repeat sequences producing small CRISPR RNAs each corresponding to a 
single spacer flanked by partial repeat sequences (Lillestol et al., 2006; Brouns et al., 
2008; Carte et al., 2008). Northern analysis of CRISPR transcripts from Pyrococcus 
furious an extremophilic archaeon suggested even further processing of the small 
CRISPR RNAs whose mature forms are finally composed of one spacer and a partial (8 
nucleotides) repeat sequence at its 5’ end known as psi-tag (Hale et al., 2009). 
c) CRISPR-interference 
The mature crRNAs guide a complex of Cas proteins towards invading DNA molecules 
allowing for their recognition via base-pairing between spacer and target sequence. 
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CRISPR/Cas interference eventually results in degradation of targeted invading 
molecules. Interestingly, spacers turned out to be complementary to both viral DNA 
strands, implying that rather dsDNA than RNA serves as a target for some CRISPR/Cas 
systems. However, contrary to studies on S. epidermidis, S. thermophilus and S. 
solfataricus (Marraffini and Sontheimer 2008; Garneau et al., 2010; Manica et al., 
2011) providing evidence that DNA serves as target for the CRISPR/Cas machinery, in 
vitro studies on P. furiosus demonstrated cleavage of invader ssRNA (Hale et al., 2009). 
These studies suggest that both DNA and RNA might act as potential targets, thereby 
providing the host organism with a more flexible immune system. Considering the 
mechanistic principle of the CRISPR/Cas system the host encounters the problem of 
potential autoimmune responses, which is a challenge for all immune systems. Thus, 
the cell has to find a way to prevent targeting of the host’s chromosome by base-
pairing of crRNA with spacer DNA encoded within the CRISPR-locus during CRISPR/Cas 
interference. Experimental data derived from tests on Staphilococcus epidermis 
strongly indicated that the flanks corresponding to CRISPR-repeat sequences in the 
crRNA are essential for self/non-self discrimination. The authors were able to 
demonstrate that matches between the flanking region upstream of the spacer and 
target sequence conferred protection to the target whereas the absence of a flanking 
repeat enabled interference (Marraffini and Sontheimer 2010). 
 
 
2.4.4 Evading the CRISPR/Cas-based immune response 
Virus-host interactions resemble a never-ending arms race primarily triggered by 
selective pressure that is constantly present within virus-host populations. Viruses able 
to circumvent CRISPR/Cas-induced immunity arise in response to ongoing adapting 
CRISPR/Cas systems. This was for example observed for virus particles that specifically 
accumulated mutations into the protospacer sequence leading to loss of resistance 
against the virus. The protospacer describes the nucleotide sequence within the virus 
genome that is complementary to the spacer. Studies focusing on bacterial systems 
initially indicated that even a single point mutation within the protospacer sequence 
permits viruses to evade CRISPR/Cas resistance (Deveau et al., 2008; Heidelberg et al., 
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2009). However, in vivo experiments on the hyperthermophilic crenarchaeon S. 
solfataricus demonstrated that immune response was still detectable to some degree 
upon infection with a virus exhibiting multiple mutations within its protospacer 
sequence (Manica et al., 2011). Consistent with these findings, recent investigations 
based on the E. coli as well as the Pseudomonas aeruginosa CRISPR/Cas system suggest 
that especially mutations within a defined protospacer region allow for evasion 
whereas mutations outside this region can be tolerated more easily by the CRISPR/Cas 
complex (Semenova et al., 2011; Wiedenheft et al., 2011). Besides, mutations within 
‘quasi’-conserved sequences adjacent to protospacers (called PAMs) (Mojica et al., 
2009) have also been claimed to be involved in the loss of phage resistance (Deveau et 
al., 2008; Mojica et al., 2009; Semenova et al., 2011). Moreover the deletion of 
protospacers as well as genome recombination events may demonstrate additional 
strategies to prevent interference (Deveau et al., 2008; Heidelberg et al., 2009). 
The last few years provided substantial insights in terms of CRISPR/Cas functionality 
and mechanistic processes, respectively. Nevertheless, many aspects that are involved 
in CRISPR/Cas induced bacterial and archaeal immune response remain obscure and 
need to be clarified by future research work. 
 
 
2.5 Demonstration of in vivo CRISPR/Cas activity in the archaeon Sulfolobus 
solfataricus 
 
2.5.1 The model organism Sulfolobus solfataricus and its associated virus SSV1 
Sulfolobus solfataricus is a hyperthermophilic Crenarchaeote of the order Sulfolobales 
and was first isolated from a solfataric field in Pisciarelli, Italy in 1980 (Zillig et al., 
1980). Since then, S. solfataricus has emerged into an intensely studied model 
organism in archaeal research that has revealed previously unknown insights into 
cellular processes and gene functions of hyperthermophilic organisms.  
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S. solfataricus grows in acidic, sulfur-rich hot springs; its optima of temperature and pH 
range from 75-78 °C and 2-3, respectively. S. solfataricus can 
be cultured relatively easily in liquid as well as on solid media 
and requires both aerobic and heterotrophic growth 
conditions (Brock et al., 1972; Grogan 1989). The genome of 
strain S. solfataricus P2 was fully sequenced and exhibits a 
size of 2.9 Mb (She et al., 2001). As the genomic DNA of S. 
solfataricus comprises high abundance of IS elements, 
transposon mutagenesis is proposed to be the dominant 
mechanism of mutation events and enabled the isolation of 
beta galactosidase- (lacS) as well as uracil-auxotrophic 
mutants containing a transposable element in the 
respective genes (Schleper et al., 1994; Martusewitsch et al., 2000). The isolation of 
the virus SSV1 (Sulfolobus shibatae virus 1) eventually provided the basis for the 
development of an efficient transfection procedure (Schleper et al., 1992) and the 
selectable shuttle vector pMJ0305 (Jonuscheit et al., 2003) in order to genetically 
manipulate S. solfataricus. SSV1 exhibits a lemon-shaped morphology (Zillig et al., 
1996) (compare Figure 2 ) and contains a circular ds-genome of 15.5 kbp. Even though 
SSV1 was originally isolated from Sulfolobus shibatae, the application of plaque assays 
demonstrated that SSV1 can also infect S. solfataricus. The virus DNA is found both as 
plasmid and integrated into the host chromosome after infection whereby the release 
of virus particles results in evident growth retardation of S. solfataricus without 
inducing cell lysis (Schleper et al., 1992). 
2.5.2 In vivo study of CRISPR-mediated virus defence in Sulfolobus solfataricus 
Manica et al. managed to establish an in vivo test system for the hyperthermophilic 
archaeon S. solfataricus to allow for the study of CRISPR/Cas related activity in the 
archaeal domain of life. In order to obtain a virus-based target that is recognized by 
the CRISPR/Cas machinery, ORF406 an open reading frame of the conjugative plasmid 
pNOB8 (She et al., 1998) containing a short nucleotide sequence highly similar to 
spacer 53 within CRISPR locus 3 of S. solfataricus strain P2 as well as ORF406 mutants 
were cloned into the recombinant SSV1 virus (pMJ0305). Subsequently, those SSV1 
Figure 2: Transmission 
electron micrograph of wild-
type SSV1 particles attached 
to a membrane fragment 
(Stedman et al., 1999). 
Source: Stedman et al. 
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mutants exhibiting either 7 bp, 3 bp, 0 bp mutations or 1 bp deletion with respect to 
spacer 53 were tested in plaque assays. The 7 bp mutations (construct 406-7M) 
correspond to those found in the ORF406 wild-type gene. Construct 406-3M (3 bp 
mutations) only contains three out of seven mutations (with respect to the spacer 
sequence) initially found in the wild-type gene. The 3 bp mutations are positioned at 
the protospacer end being complementary to the 5’-end of spacer RNA. Construct 406-
1D has 1 bp deletion in the centre of the protospacer sequence. The respective DNA 
sequences of the different versions of ORF406 are shown in Figure 3. Transfection 
efficiencies of S. solfataricus P2 with 406-mutants whose protospacer sequence 
perfectly (without mismatch) corresponded to spacer 53 were dramatically lower than 
those with seven mismatches-containing ORF406-constructs (see Figure 4). 
Unexpectedly, the 3 bp mismatch as well as the 1 bp deletion constructs yielded 
comparatively low transfection efficiencies (see also Figure 4) implying that CRISPR/Cas 
immunity is still given, albeit to reduced extent, when mutations occur within the 
protospacer sequence. In contrast, equally high transfection efficiencies for each of the 
different constructs were obtained in S. solfataricus strain M18 (see Figure 4) that does 
not carry the ORF406-specific spacer within its CRISPR loci (Manica et al., 2011).  
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Figure 3: Overview of recombinant shuttle vector and protospacer constructs. 
A. E. coli/S. solfataricus shuttle vector pMJ0305. The different ORF406 gene variants have been 
incorporated into the insertion site.  
B. DNA sequences (protospacers) of ORF406 that have been varied in the different constructs 
(highlighted in bold and underlined are the mismatches and deletion compared with the spacer 
sequence). The construct 406-0MnoP is identical to 406-0M, but without the TF55 promoter in front of 
the gene. The grey shaded region is similar/identical to the sequence of spacer53. Nucleotides depicted 
on the left and right side to the spacer53 represent the repeat region of the locus. Source: Manica et al., 
2011. 
 
 
Figure 4: Obtained transfection 
efficiencies for different SSV1 
shuttle-vector constructs. 
Source: modified from table 1, 
Manica et al., 2011. 
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2.6 The goal of this study 
 
The widespread occurrence of CRISPR/Cas based immune systems in both bacterial 
and archaeal organisms indicate their ecological relevance in shaping viral populations, 
thereby also manipulating microbial population dynamics and composition. Even 
though several studies revealed many new aspects about CRISPR/Cas functionality and 
related mechanistic processes the complete mechanism as well as its contribution to 
ecological processes is not fully understood yet. As many investigations are primarily 
focusing on bacterial CRISPR/Cas-mediated immune systems, this study aimed to learn 
more about CRISPR/Cas related functioning in the archaeal domain. 
More precisely, the primary task of the study was to explore the base-pairing 
requirement for crRNA-protospacer DNA interaction using the hyperthermophilic 
crenarchaeote Sulfolobus solfataricus as a model organism. The study involved the 
gradual introduction of increasing numbers of mutations at the two different ends of 
the protospacer DNA sequence. The generation of protospacer mutants included 
polymerase chain reaction mutagenesis as well as the usage of Gateway® Cloning 
technology. Consequently, the goal was to test the impact of both increasing number 
and differently positioned protospacer mutations on CRISPR/Cas-mediated immune 
activity via the application of plaque assays. The tested mutants included protospacer 
variants carrying from six up to ten consecutive mutations at the “up”-end of the 
protospacer (complementary to the 5’-end of spacer RNA) as well as variants 
containing consecutive mutations ranging from six up to 18 at the other end of the 
protospacer sequence. 
The investigation should serve to elucidate how tolerant the system may be towards 
protospacer mutations and which mutation positions may have the strongest impact 
on CRISPR/Cas related DNA interference. 
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3 Materials 
 
 
3.1 Microorganisms 
 
Escherichia coli Top10 Invitrogen 
 
Sulfolobus solfataricus P2 (DSM 1617) Zillig et al., 1980 
 
Sulfolobus solfataricus M18 Martusewitsch et al., 2000 
(pyrEF mutant of strain P1; DSM 1616) 
 
 
3.2 Oligonucleotides 
 
ORF406-specific primer pair Primer sequence 5’ - 3’ 
 
 
pNOB8_ORF406_fw ATACCATGGACAGCATAGGATTTTGTTTTCGAG 
pNOB8_ORF406_rw TATGGGCCCCTATGCTAGCTTAGTGGAGTGTGAG 
 
 
 
Mutagenesis primers Primer sequence 5‘ – 3‘ 
 
Rw1-406-6M-up 
 
GCAACATCGTGTAACCTCATCC 
Fw1-406-6M-over-up CTGATCCGAGCTGAAAAGCATCTTGAAG 
Fw-8M-UP GATCAGAAAACATCGTGTAACCTC 
Fw-WOP CGAGCTGAAAAGCATCTTGAA 
Fw-10M-up GATCAGAATTCATCGTGTAACCTC 
Fw-WOP CGAGCTGAAAAGCATCTTGAA 
Fw2-406-6M-down TGAGGATGAGGTTACACGATGTT 
Rw2-406-6M-over-down GTACGTTTCGGACTTTTCCACCAACT 
Rw-9M-down CGTACAAATGGATGAGGTTACAC 
Rw-WOP TTTCGGACTTTTCCACCAACT  
Fw4-406-13M-down GAGGTTACACGATGTTGCTATTCA 
Rw4-406-13M-specific TCATATGTGTACGTTTCGGACTT 
Fw3-406-14M-down AGGTTACACGATGTTGCTATTCAC 
Rw3-406-14M-over-down ATCATATGTGTACGTTTCGGACTTTTCCACCAACT 
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Fw5-406-15M-down TTGGTTACACGATGTTGCTATTC 
Rw4-406-13M-specific TCATATGTGTACGTTTCGGACTT 
Fw-18-down CGTACACATATGATTAACTACACGATGT 
Rw-WOP TTTCGGACTTTTCCACCAACT  
Fw-WOP CGAGCTGAAAAGCATCTTGAA 
Rw-WOP TTTCGGACTTTTCCACCAACT 
 
 
3.3 Media for cultivation of E. coli 
 
Luria Bertani Medium (LB-Medium) 
 for 1 litre: 
Tryptone 10 g  
Yeast extract 5 g  
NaCl 10 g  
solid medium for plating: 
Agar 15 g 
 
Antibiotics for selection 
Ampicillin 50 µg/ml 
Spectinomycin 100 µg/ml 
 
SOB-Medium 
Bacto Trypton 2 % 
Yeast extract 0.5 % 
NaCl 10 mM 
KCl 2.5 mM 
 
SOC-Medium  
SOB-Medium 
Add: Glucose 20 mM 
         Mg2 20 mM 
 
 
3.4 Media for cultivation of S. solfataricus 
 
Strain P2: 
 
Brock salts basal medium (per litre)  
100x brock solution 
(NH4)2SO4 130 g  
MgSO4 x 7 H2O 25 g  
FeCl3 x 6 H2O 2 g  
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200x brock salt solution 
KH2PO4 56 g  
MnCl2 360 mg  
ZnSO4 44 mg  
CuCl2 10 mg  
VOSO4 6 mg  
Na2MoO4 6 mg  
Na2B4O7 0.9 mg  
 
1000x bock salt solution 
CaCl2 x 2 H2O 70 g  
 
carbon sources 
tryptone 0.1% [w/v] 
sucrose 0.2% [w/v] 
→ pH was adjusted to 3 with 50 % H2SO4 
 
 
Strain M18: 
 
Brock salts basal medium (per litre)  
100x brock solution 
(NH4)2SO4 130 g  
MgSO4 x 7 H2O 25 g  
FeCl3 x 6 H2O 2 g  
 
200x brock salt solution 
KH2PO4 56 g  
MnCl2 360 mg  
ZnSO4 44 mg  
CuCl2 10 mg  
VOSO4 6 mg  
Na2MoO4 6 mg  
Na2B4O7 0.9 mg  
 
1000x bock salt solution 
CaCl2 x 2 H2O 70 g  
 
carbon sources 
tryptone 0.1% [w/v] 
sucrose 0.2% [w/v] 
→ pH was adjusted to 3 with 50 % H2SO4 
 
for complementation of uracil auxotrophy 
Uracil 0.01 mg/ml 
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Solid medium for plaque assays 
 
Brock salts basal medium (see above) 
 
carbon sources 
yeast extract 0.1% [w/v] 
sucrose 0.2% [w/v] 
 
for solidification 
MgSO4 10 mM 
gelrite 0.6 % [w/v] 
→ pH was adjusted to 3 with 50 % H2SO4 
 
 
3.5 Buffers 
 
Tris Acetate buffer (TAE-buffer) 
Tris base 242 g 
EDTA 0.5M (pH8) 100 ml 
Acetic acid 57.1 ml 
add to 1liter ddH2O 
 
TE-buffer  
Tris/HCl, pH7.5 10 mM 
EDTA 1 mM 
 
 
3.6 List of chemicals, enzymes, size markers, cloning vectors 
 
Vectors 
pCR®8/GW/TOPO® Invitrogen 
pMJ0305 Jonuscheit et al., 2003 
 
Size markers 
GeneRuler™ 1kb Plus bp DNA Ladder Fermentas 
GeneRuler™ 1kb bp DNA Ladder Fermentas 
GeneRuler™ 100 Plus bp DNA Ladder Fermentas 
 
Enzymes 
T4 polynucleotide kinase Fermentas 
T4 DNA Ligase Fermentas 
Taq DNA Polymerase Fermentas 
Phusion DNA Polymerase Finnzymes 
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Gateway® LR Clonase™ Enzyme mix Invitrogen 
BigDye® Terminator Applied biosystems 
→ all reactions were performed in buffers supplied with the enzymes 
 
Kits 
NucleoSpin® Gel and PCR Clean-up Macherey-Nagel 
E.Z.N.A® Plasmid Miniprep Kit Omega Bio-Tek Inc 
 
Chemicals 
Agarose LE Biozym 
KH2PO4 Carl Roth GmbH & Co  
MnCl2 Carl Roth GmbH & Co  
ZnSO4 Carl Roth GmbH & Co  
CuCl2 Carl Roth GmbH & Co  
VOSO4 Carl Roth GmbH & Co  
Na2MoO4 Carl Roth GmbH & Co  
Na2B4O7 Carl Roth GmbH & Co  
(NH4)2SO4 Carl Roth GmbH & Co  
MgSO4 x 7 H2O Carl Roth GmbH & Co  
FeCl3 x 6 H2O Carl Roth GmbH & Co  
CaCl2 x 2 H2O Carl Roth GmbH & Co 
Spectinomycin dihydrochloride pentahydrat Sigma 
Ampicillin Sigma 
Agar Agar Kobe I Carl Roth GmbH & Co 
Bacto Yeast Extract BD 
Glycerol Carl Roth GmbH & Co 
Sucrose Serva 
Tryptone Carl Roth GmbH & Co 
H2SO4 Carl Roth GmbH & Co 
NaCl AppliChem 
GelRite Carl Roth GmbH & Co 
Uracil Sigma-Aldrich 
 
Other materials 
MF-Millipore™ Membrane Filters Millipore 
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4 Methods 
 
4.1 Construction of shuttle vectors using Gateway® Cloning 
 
4.1.1 Vectors used for cloning 
Entry vector pEnter-406 (Figure 5) is based on pCR®8/GW/TOPO® and was used to 
generate mutations on the protospacer sequence in the ORF406. Resulting 
protospacer mutants were used for subsequent cloning into the viral shuttle-vector 
pMJ0305.  
The vector contains, beyond others, a pUC origin of replication (ori) allowing high-copy 
replication and maintenance in E. coli, spectinomycin promoter and spectinomycin 
resistance gene (aadA1) that confers resistance to the cells that have taken up the 
plasmid under transformation. Since spectinomycin inhibits the protein synthesis, cells 
that are not resistant to spectinomycin are unable to divide on selective media 
containing this antibiotic. For the purpose of CRISPR studies the Taq-amplified PCR 
product of the ORF406 was cloned into the TOPO® Cloning site of pCR®8/GW/TOPO®. 
Additionally the entry vector contains Bacteriophage λ-derived recombination 
sequences (att sites) that allow recombinational cloning of the inserted open reading 
frame ORF406 with a Gateway® destination vector (Landy 1989). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Simplified picture of the entry vector pEnter-
406. The vector is based on the cloning vector 
pCR®8/GW/TOPO® and contains pNOB8 open reading 
frame ORF406 that has been varied to obtain different 
protospacer mutants. The protospacer containing 
ORF406 is flanked by two recombination sequences (att 
sites). Source of the vector: Manica et al., unpublished 
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The destination vector (Figure 6) is based upon the E. coli/S. solfataricus shuttle vector 
pMJ0305 comprising the complete genome of virus SSV1 that has originally been 
isolated as a 15 kbp plasmid from Sulfolobus shibatae. Besides the sequence of SSV1 
the vector contains pUC18 allowing for propagation in Escherichia coli and the genes 
pyrEF (coding for orotidine-5’-monophosphate pyrophosphorylase and orotidine-5’-
monophosphate decarboxylase) of Sulfolobus solfataricus as selectable marker to 
complement pyrimidine auxotrophic mutants. Additionally, the shuttle vector encodes 
for beta lactamase providing ampicillin resistance as selection marker after 
transformation of E. coli. In order to enable gene transfer from entry to destination 
vector two att sites flanking a cassette that contains a ccdB and chloramphenicol 
resistance gene were introduced into the vector’s insertion site. The CcdB protein 
interferes with E. coli DNA gyrase (Bernard et al., 1993), thereby inhibiting growth of 
most E. coli strains (e.g. DH5α™, TOP10). When recombination between destination 
and entry vector occurs the ccdB gene is replaced by the gene that is located between 
the two att sites on the entry vector. Thus, cells that take up unreacted vectors 
carrying the ccdB gene or by-product molecules retaining the ccdB gene will fail to 
grow.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: Simplified picture of the destination 
vector pMJ0305 including a recombination 
cassette. The vector was developed by 
Manica et al., (unpublished). 
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4.1.2 Inverse PCR (Polymerase Chain Reaction) Mutagenesis 
Inverse PCR constitutes a modified form of PCR where the primers in contrast to 
common PCR are not oriented towards each other but are directed in inverse 
orientation on a circular template. This method was used to generate site-directed 
mutations on the pre-vector DNA of approximately 4 kb. For each reaction one 
sequence-specific and one primer with overhang not matching the template DNA to 
introduce the desired mutation were designed. During PCR amplification the mutation 
is integrated in the vector DNA. As Phusion DNA Polymerase provides higher fidelity 
than commonly used Taq DNA Polymerase, Phusion was used for mutagenesis PCR. 
The standard reaction mix included: 
- 5 µl of 5x Phusion buffer (+ MgCl2) 
- 0.2 mM dNTP mix 
- each 0.2 µM forward and reverse primers 
- 2 units Phusion DNA Polymerase 
- 1 µl template (1-10 ng/µl vector DNA) 
- ddH2O added to a total volume of 25 µl 
The reactions were performed in a thermocycler by use of the following program: 
Initial denaturation for 2 min at 98 °C 
- Denaturation for 15s at 98°C 
- Annealing for 20s at 56/57/60°C 
- Elongation for 4 min at 72°C  
- Final elongation was done for 5 min at 72°C. 
The denaturation step causes melting of template DNA yielding ssDNA molecules. 
Subsequent temperature lowering allows hybridisation between primer and ss 
template DNA during the annealing step. Annealing temperature is primary dependent 
on GC-content of the primer sequence and has to be calculated before reaction 
procedure. During elongation the polymerase binds to the primer-template hybrid and 
starts the synthesis of the new DNA. This step was performed at 72°C in which the 
enzyme catalyses the polymerization of approximately 1,000 nt per minute. The final 
elongation step is performed after the last PCR cycle to ensure full extension of 
remaining ssDNA. 
 
}30 cycles 
Methods 
 
26 
 
Primer-pairs as well as templates used for generation of the respective protospacer 
mutants are listed in Table 1. For primer sequences see section 3.2. 
 
Table 1: Templates and corresponding primer pairs used to create modified versions of the ORF406 
protospacer sequence. 
 
Template 
pEnter 
Construct name Primer name 
406-0M 406-6Mup 
Rw1-406-6M-up 
Fw1-406-6M-over-up 
406-6M-up 406-8M-up 
Fw-8M-UP 
Fw-WOP 
406-6M-up 406-10M-up 
Fw-10M-up 
Fw-WOP 
406-0M 406-6Mdown 
Fw2-406-6M-down 
Rw2-406-6M-over-down 
406-6M-down 406-9M-down 
Rw-9M-down 
Rw-WOP 
406-14Mdown 406-13Mdown 
Fw4-406-13M-down 
Rw4-406-13M-specific 
406-0M 406-14Mdown 
Fw3-406-14M-down 
Rw3-406-14M-over-down 
406-14Mdown 406-15Mdown 
Fw5-406-15M-down 
Rw4-406-13M-specific 
406-15M-down 406-18M-down 
Fw-18-down 
Rw-WOP 
406-0M 406-WOP 
Fw-WOP 
Rw-WOP 
 
 
After amplification the PCR product was investigated by loading a small amount of the 
sample onto a 0.8 % ethidium bromide stained agarose gel. In order to obtain the PCR 
product of the right size the band was excised from the agarose gel and purified before 
DpnI digestion. The reaction mixture was incubated at 37°C for 2 hours to remove 
template DNA from amplified mutated DNA. DpnI only hydrolyses methylated 
template DNA whereas the amplified DNA remains unmethylated during PCR reaction 
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and cannot be cut by the DpnI enzyme. Afterwards the PCR product was purified from 
remaining reaction components that might interfere with the ligation procedure.    
 
4.1.3 Ligation of vector DNA 
In order to get the circular form of the vector DNA it had to be ligated after PCR 
amplification. For the purpose of blunt-end ligation T4 DNA ligase and 25-35 ng of 
phosphorylated vector DNA were used. As the ligation procedure requires a 5’-
phosphate at the free ends of DNA the primers were phosphorylated before PCR. 
The whole reaction mixture included: 
- 5 µl of 10x T4 DNA ligase buffer 
- 5 µl of 50 % PEG4000 solution (for blunt end ligation) 
- 1 µl of T4 DNA ligase 
- 25-35 ng of linear DNA 
- ddH2O added to a total volume of 50 µl. 
The DNA ligase catalyses the formation of a covalent bond between 3’-hydroxyl ends 
with 5’-phosphate ends under ATP consumption. The reaction mixture was incubated 
overnight at 22°C. 
 
4.1.4 Primer phosphorylation 
Previous to inverse mutagenesis PCR, 100 pmol of primer were phosphorylated by T4-
polynucleotide kinase. The enzyme transfers the phosphate group from ATP to the 5’-
hydroxyl terminus of the DNA. Additionally the 20 µl reaction included 10x T4 
polynucleotide kinase buffer, 1 µl of 10 mM ATP, ddH2O and it was incubated at 37 °C 
for 1 hour. After incubation the enzyme was inactivated by freezing at -20°C. 
 
4.1.5 Agarose gel electrophoresis 
To check the quality of DNA and to separate DNA fragments of different size agarose 
gel electrophoresis was performed. For this purpose the appropriate amount of 
agarose was added to 1xTAE buffer and heated in a microwave to allow to completely 
dissolve the agarose. Before adding about 3 drops of ethidium-bromide (final 
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concentration of approximately 0.1-0.5 µg/ml) the suspension was cooled down and 
finally poured into a gel rack containing a comb. When the agarose gel was stiff the 
comb was removed and the chamber was filled with 0.5xTAE. After mixing the DNA 
samples with loading dye in a proper ratio (about 6:1) electrophoresis was performed 
at 80-120 Volt. When an electric current is applied, DNA molecules move through the 
gel from the negative to the positive pole as their phosphate backbone is negatively 
charged. The migrational velocity of the molecules is dependent on their number of 
base pairs. By using proper DNA markers containing nucleic acid fragments of known 
size, the length of the investigated DNA-molecules can be estimated. Ethidium 
bromide intercalates into double-stranded DNA-molecules and is activated by UV-light 
enabling the visualisation of nucleic acids by a specific scanning device which detects 
fluorescence signals. 
 
4.1.6 Purification of PCR products by PCR-clean up kit (NucleoSpinTM) 
After PCR amplification the PCR products were purified to avoid interference of 
remaining reaction compounds when performing subsequent reaction procedures. The 
instructions provided by the product manual were closely followed and the final 
elution step was done with 40 µl of provided EB buffer. The samples were stored at 
4°C as freezing may result in fragmentation of the PCR products. 
 
4.1.7 Excision of bands from agarose gel  
When specific DNA bands had to be excised from agarose gel the sample was loaded 
on a 1 % agarose gel to allow for initial electrophoretic separation of the designated 
DNA bands. Under UV exposition the right bands were cut out from the respective 
sample. In order to prevent DNA damage the UV exposition should be kept as short as 
possible. Subsequently the excised DNA fragments were extracted by using 
NucleoSpinTM kit. The respective protocol was closely followed and the extracted DNA 
was eluted in 60-80 µl EB buffer. 
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4.1.8 Quantification of nucleic acids 
To quantify the extracted DNA the nanodrop spectrophotometer, which calculates the 
concentration of nucleic acids by measuring UV-absorbance of DNA molecules at 260 
nm (absorption maxima of nucleic acids), was used. Only 1 µl of the respective sample 
is required for measuring. The purity of the sample is obtained from the absorption 
curve and the absorbance ratios at 260nm/280nm and 260nm/230nm. The first ratio 
gives you information about protein contamination and should ideally have a value of 
1.6-2.0 whereas the latter one gives information about contamination by other 
compounds such as phenol (absorbing at wavelength 230) and should be in the range 
of 1.8. 
 
4.1.9 Transformation of chemically competent E.coli cells 
After the designated mutations were integrated the circular vector DNA was used to 
transform chemically competent cells of E.coli strain Top10 (F-) (Invitrogen). Each time, 
25 μl of competent cells were incubated on ice with 1-5 μl of the respective ligation 
product for 15 minutes. Subsequently, the cells were heat-shocked for 30 s in a 
thermo-cycler with 42°C and immediately transferred to ice. Cell recovery was done by 
adding 200 μl of S.O.C.-Medium and regenerating at 32-37°C for at least 45 minutes 
during which the cells were shaken at 300 rpm. 
 
4.1.10 Plating of E.coli 
After regeneration the transformation mix was plated on LB plates containing either 
spectinomycin [100 μg/ml] or ampicillin [100 
μg/ml] and grown over night. In order to 
prevent recombination events between vector and chromosomal DNA of E.coli, likely 
to occur when transforming big vectors, the plates were incubated at 28-32°C. 
According to vector size different concentrations of antibiotics were used, e.g. for big 
vectors (> 20 kb) only half of the concentration which means [50 μg/ml] was added to 
the plates. The addition of antibiotics to the culture medium allows for the selection of 
transformed E.coli cells. As there is an antibiotic resistance gene located on the 
plasmid only those cells carrying the plasmid will survive. 
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4.1.11 Plasmid purification from transformed E.coli cells 
Plasmids were purified from single clones of transformed E.coli cells by use of the 
E.Z.N.A. Miniprep Kit. Prior to plasmid purification, single colonies were picked and 
inoculated in 5-7 ml of liquid LB-medium supplied with either spectinomycin [100 μg/ml] 
or ampicillin [50 μg/ml] and grown over night at 28-32°C. The cells were harvested by 
centrifuging at 4,000 rpm for 10 min and the supernatant was discarded. Plasmid 
purification was performed as described in the manufacturer’s manual. 
 
4.1.12 Polymerase Chain Reaction (PCR) 
The polymerase chain reaction provides the opportunity to amplify specific DNA 
regions such as genes or non-coding DNA sequences. In order to check for the 
presence of the mutated ORF406 a specific primer pair (pNOB8_ORF406_fw, 
pNOB8_ORF406_rw; see section 3.2 ) targeting the 1.2 kb DNA fragment located on 
the transformation vector was used for amplification. 
The standard reaction mix included: 
- 5 µl of 5xTaq Polymerase buffer 
- 0.2 mM dNTP mix 
- 2 mM MgCl2 
- each 0.2 µM forward and reverse primers 
- 2 units Taq DNA Polymerase 
- 1 µl template (1-10 ng/µl vector DNA) 
- ddH2O added to a total volume of 25 µl. 
The corresponding PCR program was as follows: 
- Initial denaturation for 2 min at 95 °C 
- Denaturation for 15s at 95 °C 
- Annealing for 20s at 52 °C 
- Elongation for 1.20 min at 72°C  
- Final elongation was done for 5 min at 72°C. 
 
When PCR was directly performed on E.coli transformants (colony PCR), single colonies 
were picked with a sterile pipette tip, transferred in PCR tubes and used as template 
 
}34 cycles 
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for PCR amplification. In the case of colony PCR initial heating was extended to ensure 
cell destruction and by this to free enough template for the reaction. 
 
4.1.13 Sequence reaction and determination 
To determine defined regions of DNA sequences and/or to check for the accuracy of 
inserted mutations the purified plasmids were used for sequencing. For this purpose 
the dye termination sequencing procedure was used. In order to obtain sequence 
fragments of diverse length the dNTP mix also included fluorescently labelled 3’-
didesoxyribonucleosidtriphosphates (ddNTP). As the ddNTPs lack the hydroxylgroup on 
the 3’ C-atom strand synthesis is interrupted each time a fluorescently labelled 
nucleoside is attached. The reaction mix included the following components: 1.5 μl Big 
Dye Chemistry (ABI, Applied Biosystems), 1 μl 5x Sequencing Buffer (Applied 
Biosystems), 5 pmol primer (either forward or reverse), 20-25 ng template DNA 
(purified PCR product) and ddH2O to a final volume of 10 μl. When more than one 
clone had to be analysed, a master mix was prepared. The reaction was conducted in a 
thermo cycler by use of the following program: Initial heating step at 96°C for 1 min 
and 30 cycles of [denaturation at 96°C for 20 s, annealing at 52°C for 15 s, elongation 
at 60°C for 4 min]. The sequence identification was carried out by use of an ABI 
capillary DNA Sequencer.  
 
4.1.14 Sequence analysis 
The DNA sequence was determined for three to five randomly chosen clones per 
vector construct. After proofreading the sequences by use of the chromatogram, a 
sequence alignment was performed with ClustalW 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/). The less well resolved ends of the 
sequences were removed previous to sequence alignment. Only those vectors whose 
DNA sequence revealed the accurate mutations in the protospacer region were chosen 
for subsequent Gateway® recombination. 
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4.1.15 Gateway® Recombination (LR reaction) 
In order to transfer the att-flanked gene from the entry clone to the destination vector 
the so called LR reaction was performed. The reaction is mediated by an enzyme 
mixture called LR Clonase®, which contains the necessary protein activity to excise the 
gene from the entry clone and integrate it into the destination vector. 
Gateway® LR Clonase™ II enzyme mix contains a proprietary blend of Int 
(Integrase),  IHF (Integration Host Factor) and Xis (Excisionase) enzymes that catalyze 
the in vitro recombination between entry clone and destination vector. 
The reaction mixture included following components: 
- 150 ng of entry vector 
- 680 ng of destination vector 
- 2 µl of Gateway® LR Clonase™ II enzyme mix 
- TE-buffer added to a total volume of 10 µl 
The mixture was incubated overnight at 25°C. 
2 µl of the reaction mixture were used for subsequent transformation into E. coli cells 
(E. coli TOP10). 
 
4.1.16 Glycerol stocks of transformed E.coli colonies  
To be able to conserve positive clones that have taken up plasmids glycerol stocks 
were made. For this purpose the overnight E.coli culture was mixed with sterile 100 % 
glycerol in the ratio of either 1:1 or 1:1.5 (for pMJ0305 constructs). The glycerol stocks 
were stored at -80°C. 
 
 
4.2 Growth of Sulfolobus solfataricus 
 
4.2.1 Liquid culture 
Strain S. solfataricus P2 was grown in 50-200 ml Brock’s medium (Grogan, 1989) 
containing 0.1% (w/v) tryptone and 0.2% sucrose at pH 3 adjusted with 50 % H2SO4. 
Long-neck bottles were filled with basal media and a defined volume of pre-culture or 
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300 µl of 10x concentrated S. solfataricus glycerol stocks were inoculated and 
incubated at 78°C in a shaking oil-bath providing highly aerobic conditions. The optical 
density of liquid cultures was monitored at 600 nm. 
 
4.2.2 Conservation of Sulfolobus solfataricus 
 
4.2.2.1 Glycerol stocks 
Exponentially grown cells were cooled down and centrifuged at 4,000 rpm for 10 min 
at 4°C. The supernatant was discarded and the cell pellet was resuspended in Brock’s 
basal medium supplemented with 25% glycerol. The cell suspension was stored at -80 
°C. 
 
4.2.3 Transfection of Sulfolobus solfataricus 
 
4.2.3.1 Dialysis of vector DNA 
As increased conductivity due to high salt concentrations (e.g. buffer salts) may lead to 
disturbances during the electroporation procedure vector DNA had to be dialysed first. 
For this purpose ddH2O was supplemented with 0.05mM Tris-HCl (final concentration) 
and a filter disc (Millipore, pore size 0.025 µm) was put on the liquid surface. 20-40 µl 
of vector DNA were pipetted on the filter disc and dialysed for 2 h at room 
temperature. Subsequently DNA was quantified with a nano-Drop spectrometer 
(Peqlab) and used for electroporation of S. solfataricus cells.  
 
4.2.3.2 Electroporation of Sulfolobus solfataricus 
Beside some modifications due to optimization reasons the electroporation of S. 
solfataricus cells was performed as described in Kurosawa and Grogan (Kurosawa and 
Grogan 2005). 
Exponentially grown S. solfataricus P2 cells were used for the preparation of 
competent cells previous to electroporation. 150 ng of dialysed viral DNA were mixed 
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with 50 µl competent cells and pipetted into cooled cuvettes (1mm gap). Subsequent 
electroporation was performed by the use of Gene Pulser Xcell (BioRad). Instrument 
adjustments were as follows: 1250V, 25µF, 1000Ω . The cells were regenerated in 50 µl 
pre-warmed recovery solution (Berkner et al., 2007) for 45-60 min at 75°C immediately 
after electroporation. A defined volume of transformation mixture was used for 
subsequent plating (plaque assay). 
 
4.2.3.3 Preparation of electrically competent Sulfolobus solfataricus cells 
For the preparation of competent P2 cells an overnight culture having an optical 
density (OD600) of approximately 0.18 was cooled down in ice water and centrifuged 
for 10 min at 4,000 rpm and 4°C. In order to remove the salts the cells were washed by 
gently resuspending the cell pellet in 20 ml of ice-cold 20mM D-sucrose. This step was 
repeated three times. A final concentration of 10^10 cells/ml was adjusted by adding 
the appropriate volume of 20mM D-sucrose and this was used for subsequent 
electroporation.    
 
 
4.3 Plaque assay 
 
4.3.1 Media preparation 
Solid medium was directly prepared before plating and consisted of 0.6% gellan gum 
(gelrite), 10 mM MgSO4, 0.1% (w/v) yeast extract, 0.2% sucrose and Brock’s medium. 
As the plates were incubated at 80 °C the more heat resistant gelrite instead of agar 
was used for solid media. Gelrite is a polysaccharide composed of uronic acids and 
requires an increased fraction of bivalent cations in the medium for crosslinking. 
 
4.3.2 Plating 
For the S. solfataricus P2 lawn 280 µl of 10 times concentrated exponentially growing 
cells were added to 2.8 ml of pre-warmed Brock salts supplemented with 0.4 % gelrite. 
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After adding 5-12 µl of transfected cells the mixture was quickly poured on pre-
warmed solid gellan gum plates and incubated in humid atmosphere at 78°C. When S. 
solfataricus M18 cells were used in overlays, the 10 times concentrated cell suspension 
was supplemented with uracil to ensure sufficient formation of cell lawn. Each 280 µl 
of 10x concentrated cells as well as 1 µl of transfected M18 cells were used for 
subsequent plating. The volume was reduced to 1 µl of transfected cells (compared to 
5-12 µl of transfected P2 cells) as resulting plaques were clearly bigger in size than 
those formed when using S. solfataricus P2 cells in plaque tests. Plaques were formed 
after 2 days of incubation. 
 
4.3.3 Determination of transfection efficiency 
Transfection efficiencies were determined in duplicate and triplicate respectively by 
counting plaque forming units (PFU) on gelrite plates with transformants of strain S. 
solfataricus P2 and cell lawns of P2 or with transformants of strain M18 and lawns of 
strain M18, respectively. Maximal transfection efficiencies for strain P2 varied in the 
different experiments. Therefore, transfection efficiencies were normalized in Table 2 
and Table 3 to the highest plaque count obtained in each single experiment. 
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5 Results 
 
 
5.1 Design of protospacer variants for the recombinant virus SSV1 
In order to determine the requirement for base-pairing between crRNA and 
protospacer in S. solfataricus various protospacer mutants were constructed and 
tested in the S. solfataricus/SSV1 system in transfection experiments. Initially two 
constructs both carrying six consecutive nucleotide substitutions but differently 
located within the protospacer were generated. Construct 406-6Mup contained six 
mutations at positions +1 to +6 whereas construct 406-6Mdown carried mutations at 
positions +32 to +37 within the protospacer sequence. Since these constructs yielded 
divergent results, mutations were gradually increased at both sides of the protospacer 
obtaining constructs 406-8Mup, 406-10Mup, 406-9Mdown, 406-13Mdown, 406-
14Mdown, 406-15Mdown and 406-18Mdown. All protospacer mutations refer to 
spacer 53 that is located within the active CRISPR locus 3 of S. solfataricus P2. 
Construct 406-WOP (without protospacer; obtained from Ziga Zebec, unpublished) 
contained ORF406 but lacked the spacer 53 corresponding protospacer sequence and 
served as a control to check whether the ORF406 sequence itself can affect 
transfection efficiency with respect to the native recombinant viral-vector pMJ0305. 
DNA sequence of each protospacer variant is depicted in Figure 7. For a better 
understanding the single nucleotide positions within the protospacer are numbered 
from +1 up to +37. Protospacer position +1 refers to the first crRNA position 
immediately followed by the eight nucleotide repeat-derived flanking sequence. 
Subsequent positions are referred to as 2, 3, 4, etc. ending with 37 being the last 
position of the protospacer. The designation “up” describes the protospacer 
corresponding end of the crRNA region that is adjacent to the repeat-derived flanking 
sequence whereas “down” indicates the opposite end of the protospacer.  
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          +1       +10       +20       +30 
           |        |         |         |        
5’-AUUGAAAGUGAAUAGCAACAUCGUGUAACCUCAUCCUCAGCCUUC-3’ spacer RNA 
      |   |||||||||||||||||||||||||||||||||||||| 
3‘-AGTCGAGCACTTATCGTTGTAGCACATTGGAGTAGGAGTCGGAAGAAAGCCTG-5‘ 
  
 
 
 
 
 
 
 
   AGTCGAGCACTTATCGTTGTAGCACATTGGAGTAGGAGTCGGAAGAAAGCCTG  406-0M 
   ........CTAGTC....................................... 406-6M-up 
   ........CTAGTCTT..................................... 406-8M-up 
   ........CTAGTCTTAA................................... 406-10M-up 
 
   .......................................ACATGC........ 406-6M-down 
   ....................................TACACATGC........ 406-9M-down 
   ................................AGTATACACATGC........ 406-13M-down 
   ...............................TAGTATACACATGC........ 406-14M-down 
   ..............................TTAGTATACACATGC........ 406-15M-down 
   ...........................CAATTAGTATACACATGC........ 406-18M-down 
           |    |   |         |       |   |    | 
          +1   +6  +10       +20     +28 +32  +37 
 
 
 
 
 
   AGTCGAGCACTTATCGTTGTAGCACATTGGAGTAGGAGTCGGAAGAAAGCCTG 406-WOP  
 
 
Figure 7: A) RNA sequence of spacer 53 (highlighted in light blue). The green region represents the 8 nt 
repeat-derived flanking sequence that is predicted to stay attached to the processed crRNA. The 
sequence below represents the corresponding shuttle virion SSV1 encoded protospacer (-) DNA 
sequence. “Up” describes the protospacer region adjacent to the 8 nt repeat-derived flanking sequence. 
“Down” corresponds to the opposite protospacer region. B) DNA sequence of sp53 corresponding 
protospacer (406-0M) as well as DNA sequences of engineered protospacer mutants (below). 
Introduced mutations are indicated in red. The 37 nt long protospacer region within ORF406 is 
highlighted in blue. C) Control construct 406-WOP lacks the sp53 corresponding protospacer sequence. 
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5.2 Generation of protospacer variants 
 
5.2.1 Site-directed mutagenesis via inverse PCR (Polymerase Chain Reaction) 
The application of inverse polymerase chain reaction mutagenesis enabled the 
introduction of mutations at defined regions in the protospacer sequence by 
amplifying the entire entry vector carrying the corresponding open reading frame, 
ORF406 at the same time. For the purpose of PCR mutagenesis two complementary 
primers, one of them carrying the desired mutations were used for amplification, in 
which 1-10 ng of ORF406 containing entry vector (pEnter-406) was used as a template. 
The extension of mutagenic primers results in the incorporation of the desired 
mutations (Figure 8). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Scheme of applied polymerase chain reaction (PCR) mutagenesis. Red indicates mutations 
introduced via the usage of mutagenic primers. Fw=forward primer, Rv=reverse primer 
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Subsequent to PCR mutagenesis, the amplification products were checked for their 
nucleotide lengths expected to be 4 kb in size. As expected, the application of the 
respective mutagenic primers resulted in the amplification of the 4 kb vector DNA. 
However, in addition to an intense DNA band exhibiting the correct length of 4,000 
bp’s, faint unspecific bands of various sizes could be detected on the agarose gel. Thus, 
the PCR reaction mixtures were loaded on a preparative gel and only those bands 
being 4 kb in size were excised from the gel (Figure 9) and used for subsequent vector 
re-closure. 
Figure 9 shows obtained amplification products generated by PCR mutagenesis that 
were selected for the subsequent ligation and transformation procedure. Applied 
annealing temperatures are cited next to the corresponding amplification product 
name. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: 0.8 % agarose gels (stained with ethidium-bromide) showing products of mutagenesis PCR. 
Entry vector was used as a template. Amplification was done with specifically designed mutagenic 
primers using two different annealing temperatures for each primer pair. A: 1) pEnter-406-15Mdown; 
t=56 °C 2) pEnter-406-13Mdown; t=56 °C. B: 1) pEnter-406-14Mdown; t=60.2 °C 2) pEnter-406-6Mup; 
t=60.2 °C 3) pEnter-406-6Mdown; t=60.2 °C C: 1) pEnter-406-WOP; t=57 °C 2) pEnter-406-8Mup; t=57 °C 
3) pEnter-406-10Mup; t=57 °C. 4) pEnter-406-9Mdown; t=57 °C 5) pEnter-406-18Mdown; t=57 °C. LM: 
DNA ladder mix; 1 kb. t: annealing temperature. 
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In order to enable ligation of the mutated linear vector DNA, primers used for PCR 
mutagenesis were phosphorylated prior to the amplification procedure. After DpnI 
digestion the amplified vector was blunt-end ligated by the addition of T4 DNA-ligase 
and used to transform chemically competent E. coli TOP10 cells.  
 
 
5.2.2 Verification of the mutated protospacer regions 
As exemplified by the agarose gel in Figure 10 , three to five single colonies per 
protospacer construct were selected and initially screened for the presence of ORF406. 
For this purpose primer pair pNOB8_ORF406_fw and pNOB8_ORF406_rw targeting the 
respective vector region (ORF406) being 1.2 kb in size was used for colony PCR on 
obtained E. coli clones. The amplification products were then visualized on a 1 % 
agarose gel. In most cases, a distinct band of the expected size (1.2 kb) was visible on 
the agarose gel. Each three of the investigated clones that yielded an amplification 
product of 1.2 kb were chosen for plasmid purification and subsequent Sanger 
sequencing. The obtained sequences were analyzed by use of ClustalW 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/) a freely available internet-based 
alignment tool. Each one of the analysed vectors revealing to carry the desired 
protospacer mutations was used for cloning of the different ORF406 variants into the 
SSV1 virus-derived shuttle vector pMJ0305. 
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Figure 10: 1 % ethidium-bromide stained agarose gel showing products of colony PCR using ORF406-
specific primer pair pNOB8_ORF406_fw and pNOB8_ORF406_rw. Each three to four clones of the 
different constructs were used as template. 1) pEnter-406-14Mdown_C1 2) pEnter-406-14Mdown_C2 3) 
pEnter-406-14Mdown_C3 4) pEnter-406-14Mdown_C4 5) pEnter-406-14Mdown_C5 6) pEnter-406-
6Mup_C1 7) pEnter-406-6Mup_C2 8) pEnter-406-6Mup_C3 9) pEnter-406-6Mup_C4 10) pEnter-406-
6Mup_C5 11) pEnter-406-6Mdown_C1 12) pEnter-406-6Mdown_C2 13) pEnter-406-6Mdown_C3 14) 
pEnter-406-6Mdown_C4 15) pEnter-406-6Mdown_C5. LM) DNA ladder mix; 100 bp plus. C) control. 
 
 
5.2.3 Cloning strategy for the generation of SSV1 protospacer mutants 
In order to generate different SSV1 protospacer mutants the mutated ORF406 
sequences had to be cloned into the S. solfataricus/E. coli shuttle vector pMJ0305. This 
was achieved by the application of Gateway® Cloning which is based on the site-
specific recombination system of bacteriophage lambda. Both entry (pEnter-406) and 
destination vector (pMJ0305) carry bacteriophage λ-derived recombination sequences 
(att sites) that allow for recombinational transposition of ORF406 that is situated 
between two recombination sequences. Based on the recombination procedure 
initiated by enzymatic activity, the mutated ORF406 sequences were integrated into 
the modified destination vector pMJ0305 containing the corresponding recombination 
cassette. Unreacted destination vectors still carry the ccdB gene that prevents growth 
of cells taking those vectors. This enabled the selection for recombined destination 
LM C   1    2   3    4     5    6   7    8    9   10   C   LM 
LM C  11  12  13  14  15  C  LM 
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vectors. Figure 11 depicts a simplified scheme of the applied cloning strategy based on 
Gateway® Cloning. 
 
 
Figure 11: Principle of applied Gateway® Cloning. Mutated versions of ORF406 were transferred from 
entry vector pEnter-406 to E. coli/S. solfataricus shuttle vector pMJ0305 via recombinational cloning. 
 
Entry and destination vector were added to the reaction mixture by applying a ratio of 
about 1:1. The mixture was incubated overnight and used for subsequent 
transformation of E. coli. In order to select for the desired transformants the cells were 
grown on ampicillin [50 μg/ml] containing LB-plates. In each case a large amount of 
clones could be obtained, some of which were selected for plasmid purification.   
 
5.2.4 Detection of ORF406 inserts and determination of vector DNA topology 
The obtained E. coli transformants were examined for the presence of the mutated 
ORF406 sequence within the SSV1-based destination vector pMJ0305. Hence, three to 
four clones each were chosen for colony PCR using primer pair pNOB8_ORF406_fw and 
pNOB8_ORF406_rw. Each two to three positive clones were finally utilized to isolate 
the DNA of the respective SSV1 shuttle-vector constructs. 
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As DNA topology affects the efficiency of the transformation/transfection procedure, 
each construct was checked for its topology prior to transfection of S. solfataricus. For 
this purpose the isolated vector DNA was visualized on a 0.8 % agarose gel and 
examined for both purity and topology (Figure 12). Only SSV1 shuttle vectors showing 
correct topology were chosen for transfection experiments. 
Figure 12 shows DNA samples of isolated SSV1 vector constructs, some of which 
exhibiting different DNA topology. Only those samples framed in yellow were used for 
transfection of S. solfataricus. The different bands per lane illustrate distinct 
topological forms of vector DNA which are explained in Figure 13. The different 
topological forms of DNA affect its migration velocity during agarose gel 
electrophoresis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: 0.8 % agarose gel showing SSV1 shuttle-vector constructs. 1) pMJ0305-406-9Mdown_C1 2) 
pMJ0305-406-9Mdown_C2 3) pMJ0305-406-9Mdown_C3 4) pMJ0305-406-18Mdown_C1 5) pMJ0305-
406-18Mdown_C2 6) pMJ0305-406-18Mdown_C3 7) pMJ0305-406-WOP_C1 8) pMJ0305-WOP_C2 9) 
pMJ0305-406-WOP_C3 10) pMJ0305-406-8Mup_C1 11) pMJ0305-406-8Mup_C2 12) pMJ0305-406-
8Mup_C3 13) pMJ0305-406-10Mup_C1 14) pMJ0305-406-10Mup_C2 15) pMJ0305-406-10Mup_C3 16) 
pMJ0305-406-13Mdown_C1 17) pMJ0305-406-13Mdown_C2 18) pMJ0305-406-14Mdown_C1 19) 
pMJ0305-406-6Mup_C1 20) pMJ0305-406-6Mdown_C1 21) pMJ0305-406-15Mdown_C1 22) pMJ0305-
406-15down_C2 23) Control: pMJ0305. LM) DNA ladder mix; 1 kb plus. Orange squares: SSV1 shuttle-
vector constructs used for transfection experiments. 
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5.3 In vivo CRISPR/Cas mediated interference studies in Sulfolobus 
solfataricus 
 
5.3.1 Transfection of strain S. solfataricus P2 carrying the corresponding spacer 
Sulfolobus solfataricus strain P2 contains several clusters of CRISPR-associated repeats. 
One of these loci (CRISPR locus CR3) includes spacer 53 whose sequence is 
corresponding, more or less (dependent on the respective construct) to the ORF406 
protospacer region of the different SSV1 shuttle-vector constructs. Thus, strain P2 
carrying spacer 53 was used as a host in order to provide potential immunity against 
the engineered SSV1 protospacer mutants. Exponentially grown overnight cultures of 
S. solfataricus P2 were used as recipients in electroporation experiments with the 
various vector constructs. The constructs were tested by using either the same (for 
constructs 406-6Mup, 406-6Mdown, 406-13Mdown, 406-14Mdown and 406-
15Mdown; see also Figure 12) or two different (for constructs 406-WOP, 406-8Mup, 
406-10Mup, 406-9Mdown, 18Mdown; see also Figure 12) vector DNA preparations 
each, in various transfection experiments. Each construct was tested in at least four 
independent experiments. In order to supply equal amounts of vector DNA when 
electroporating P2 competent cells, the DNA concentration of each construct was 
Figure 13: 0.8 % agarose gel visualizing 1) open circle (upper band) 
and linear form of SSV1 shuttle-vector DNA. 2) open circle (upper 
band), linear (middle band) and supercoiled (lower band) form of 
SSV1 shuttle-vector DNA. LM) DNA ladder mix; 1 kb plus. 
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previously determined by spectrophotometry. Subsequent to regeneration of the 
electroporated cells, the cell suspension was used in plaque assays. 
 
5.3.2 Visualization of transfectants in plaque assays 
To allow for the detection of successful viral infection, transfected S. solfataricus P2 
cells were used in plaque tests. For this purpose, a defined volume (see section 4.3.2) 
of the transfected cell suspension was mixed with spacer-containing strain P2 host 
cells in melted gelrite and plated on the surface of a Brock’s sucrose-yeast medium 
containing gelrite plate. The transfection mixtures were plated in duplicates or 
triplicates, respectively. If the introduced viral shuttle-vector successfully proliferates 
within a host cell, it will initiate infection of surrounding host cells growing on the 
plate. In consequence of virus infection, those cells are retarded in growth and can be 
seen as a light area, called plaque in the lawn of P2 overlay cells. Plaques obtained 
from different viral vector constructs were comparable in form and size whereas 
constructs yielding comparatively low transfection efficiencies generally exhibited 
plaques being smaller in size (compare Figure 14 ). 
 
 
               
 
 
Figure 14: Effects of CRISPR/Cas-mediated immunity on plaque formation. Shown plaques were 
obtained after plating cells of S. solfataricus P2 transfected with virus construct 406-6M-down (A) or 
406-6M-up (B) on cell lawns of S. solfataricus P2 carrying the respective spacer. 
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5.3.3 Quantification of transfectants by determining plaque forming units (PFU’s)  
To obtain a measure of efficient transfection of P2 cells the number of plaque forming 
units (PFU) had to be determined for each experiment. For this purpose, plaques 
obtained from the various plaque assay experiments were counted and transfection 
efficiencies of the different SSV1 shuttle-vector constructs were calculated per µg of 
applied vector DNA. As maximal transfection efficiencies for strain P2 varied in the 
separate plaque tests, the calculated transfection efficiencies were normalized to the 
highest plaque count obtained in each single experiment.  
In order to explore if differently positioned mutations within the protospacer may 
entail differences in CRISPR/Cas-mediated immune capacity, initially two different 
SSV1 shuttle-vector constructs namely 406-6Mup (mutations at positions +1 to +6; see 
Figure 7 ), 406-6Mdown (mutations at positions +32 to +37; see Figure 7. ) were 
generated and tested in plaque assays. As depicted in Figure 15 the two constructs 
showed significant differences when comparing transfection efficiencies. Construct 
406-6Mup reached 75 % (see Table 2) transfection efficiency whereas 406-6Mdown 
showed only about 4 % (Table 2) transfection efficiency. To further investigate if there 
is indeed a difference in the need of base complementarity between the two sides, six 
additional protospacer mutants were generated. These included two constructs 
carrying eight mutations at protospacer “up” positions +1 to +8 (406-8Mup) and ten 
mutations at positions +1 to +10 (406-10Mup), respectively as well as four constructs 
exhibiting a stepwise increase of consecutive mutations at the opposite side (“down”) 
of the protospacer sequence. These “down” side mutations were situated at positions 
+29 to +37 (406-9Mdown), +25 to +37 (406-13Mdown), +24 to +37 (406-14Mdown), 
+23 to +37 (406-15Mdown) and at positions +20 to +37 (406-18Mdown). The 
respective DNA sequences of the various protospacer constructs are depicted and 
specified in Figure 7. 
When constructs 406-8Mup and 406-10Mup were tested in plaque assays, both caused 
a massive reduction in CRISPR/Cas interference obtaining only slightly lower 
transfection efficiencies (Figure 15, Table 2) than the viral shuttle-vector without 
protospacer (406-WOP). 
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However, as evident from Figure 15 only 18 mutations (406-18Mdown) in the 
protospacer “down” region totally restrained (90 % transfection efficiency) CRISPR/Cas 
-mediated immune response. When 15 consecutive mutations (construct 406-15down) 
were introduced at the “down” region of the protospacer, the system was still able to 
trigger immunity in about 50 % of transfection events (Figure 15). Moreover the 
obtained values reveal that the increase of mutations referred to both sites of the 
protospacer gradually lowers CRISPR interference, albeit considerably more effective 
within the protospacer “up” region. 
Unexpectedly, the construct 406-13Mdown yielded significantly higher transfection 
efficiencies than constructs 406-14Mdown and 406-15Mdown despite its lower degree 
of mutation. Even though transfection efficiencies obtained from construct 406-
15Mdown were higher than those obtained from 406-14Mdown, they still tended to 
fall below those of 406-13Mdown.  
 
 
 
Figure 15: Bar chart showing efficiencies of plating (in %) for different recombinant SSV1 protospacer 
mutants. Transfection efficiencies were normalized to the highest plaque count obtained in each single 
experiment. Each construct was tested in at least four independent transfection experiments. Error bars 
indicate standard deviations. 
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Table 2: Transfection efficiencies obtained for recombinant virus SSV1 carrying 
different protospacer inserts. 
 
Strain Construct Average SD 
P2 pMJ0305 9,89E-01 2,11E-02 
 
406-WOP 9,76E-01 4,24E-02 
 
406-6M-up 7,51E-01 9,04E-02 
 
406-8M-up 8,68E-01 8,43E-02 
 
406-10M-up 8,01E-01 7,01E-02 
 
406-6M-down 3,62E-02 7,29E-02 
 
406-9M-down 3,39E-01 1,32E-01 
 
406-13M-down 6,52E-01 1,60E-01 
 
406-14M-down 3,20E-01 5,24E-02 
 
406-15M-down 5,39E-01 8,51E-02 
 
406-18M-down 9,02E-01 7,01E-02 
 
a. ≥ 4 independent transfection experiments for each construct. 
SD, standard deviation 
 
 
 
5.3.4 Transfection of construct 406-13Mdown, 406-14Mdown and 406-15Mdown 
using S. solfataricus strain M18 as host cells 
Contrary to expectation construct 406-13Mdown obtained higher transfection 
efficiencies than construct 406-14Mdown and even 406-15Mdown. Based on that 
observation we initially speculated that arising transfection efficiencies of these three 
constructs might have been biased by differences in viral vector DNA quality or 
inaccurate DNA quantification. To exclude the possibility that CRISPR/Cas function 
unrelated factors affected calculated transfection efficiencies, constructs 406-
13Mdown, 14M-down and 15Mdown were checked for their capacity to infect S. 
solfataricus strain M18 as host cells. S. solfataricus M18 is a close relative of strain P2 
but differs in spacer composition including the absence of ORF406-specific spacer 53. 
For subsequent plaque tests again cells of S. solfataricus strain M18 instead of P2 were 
used in overlays. 
Nearly equally high values were obtained for constructs 406-13Mdown, 14Mdown, 
15Mdown and the ORF406-missing viral vector pMJ0305, used as a control in the 
transfection experiment (Figure 16, Table 3). Due to comparatively large plaque sizes 
and difficulties with transfection of M18 cells, respectively proper PFU values could 
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only be calculated for a single (out of four) transfection experiment. Consequently, 
standard deviations for transfection efficiencies of S. solfataricus M18 are missing in 
Figure 16 and Table 3. 
 
 
 
Figure 16: Bar chart showing efficiencies of plating (in %) for constructs 406-13Mdown, -
14Mdown and -15Mdown when using either S. solfataricus strain P2 (grey bars) or strain 
M18 (blue bars) that is missing the complementary spacer for transfection experiments. 
pMJ0305 was used as a control. Error bars indicate standard deviations. 
 
 
Table 3: Transfection efficiencies obtained for recombinant virus SSV1 
carrying different protospacer inserts. 
 
Strain Construct Average SD 
P2 pMJ03 9,89E-01 2,11E-02 
 
13M-down 6,52E-01 1,60E-01 
 
14M-down 3,20E-01 5,24E-02 
 
15M-down 5,39E-01 8,51E-02 
    
M18 pMJ03 9,48E-01 
 
 
13M-down 1 
 
 
14M-down 9,56E-01 
 
 
15M-down 9,88E-01 
 
a. ≥ 4 independent transfection experiments for strain P2. 
SD, standard deviation 
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6 Discussion 
 
 
This study aimed to closer investigate the requirements for base-pairing between 
crRNA and protospacer during CRISPR interference in the hyperthermophilic archaeon 
S. solfataricus.  
The development of an in vivo test system allowed to confirm CRISPR activity in S. 
solfataricus and has been achieved by the implementation of an engineered 
protospacer carrying viral vector (Manica et al., 2011). That system is based on the 
SSV1 viral shuttle-vector pMJ0305 carrying an artificially introduced protospacer 
sequence and served in this study to test several different protospacer mutants for 
their effect on CRISPR-mediated immune response in transfection experiments.  
The previous study of Manica et al. has already revealed that up to three mutations 
within the engineered pNOB8-derived ORF406 protospacer sequence of the 
recombinant SSV1 virus are tolerated and still allow triggering CRISPR/Cas immunity 
(Manica et al., 2011). Within the scope of this diploma thesis, additional ORF406 
variants carrying different mutations within the corresponding target protospacer 
region were generated to gain a better understanding of CRISPR/Cas interference 
functioning and requirements, respectively. For this purpose polymerase chain 
reaction mutagenesis was performed to obtain desired protospacer mutants. The 
resulting ORF406 constructs were cloned into the viral shuttle-vector pMJ0305 by the 
application of Gateway® Cloning and used for subsequent transfection of S. 
solfataricus strain P2 that contains the corresponding spacer within one of its CRISPR 
loci. The application of plaque assays finally enabled to detect and compare in vivo 
CRISPR activity that has been triggered by the different viral protospacer mutants.  
When constructs 406-6Mup and 406-6Mdown, carrying six mutations each but on 
different sides of the protospacer, were tested in transfection experiments they 
revealed an obvious variation in efficiency of transformation. While 406-6Mup 
(mutations at positions +1 to +6) obtained 75 % transfection efficiency, construct 406-
6Mup (mutations at positions +32 to +37) hardly caused plaque formation showing 
only 4 % transfection efficiency. The fact that mutations at positions +32 to +37 allow 
substantially less viral escape compared with mutations occurring at the opposite end 
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of the protospacer suggests that CRISPR interference is strongly dependent on base-
pair formation at crRNA positions that are immediately followed at the repeat-derived 
flanking sequence. This initial hypothesis was supported when mutations were 
gradually increased at both sides of the protospacer. Contrary to mutations occurring 
at positions +1 to +10, the system appeared to be more permissive towards mutations 
present at opposite positions (“down”) within the protospacer sequence. While eight 
mutations at positions +1 to +8 hardly triggered CRISPR interference activity, fifteen 
mutations at positions +23 to +37 still conferred viral resistance in 50 % of transfection 
events. Surprisingly, thirteen mutations (positions +25 to +37) at the “down” end 
conferred significantly less resistance (65 compared to 32 % transfection efficiency; 
see Figure 15 and Table 2) than fourteen mutations (positions +24 to +37) at the same 
end of the protospacer. Transfection of S. solfataricus strain M18 (see section 5.3.4) 
that does not contain the ORF406-specific spacer supported that the obtained, 
unexpected high transfection efficiency for the thirteen mutations carrying construct 
(406-13Mdown) has not been affected by some CRISPR/Cas function unrelated factors. 
Thus suggesting that the unexpected (compared to construct 406-14Mdown and 406-
15Mdown) high number of plaques (per µg of DNA) obtained when strain P2 was 
transfected with construct 406-13Mdown, may be ascribed to a characteristic of the 
CRISPR/Cas mechanism that is currently unknown. 
Similar to observations made in this study, Semenova et al. have only recently 
reported that single mutations within the first seven nucleotides of the protospacer 
called “seed” (corresponding to crRNA positions immediately following the 5’-repeat-
derived flanking sequence) led to viral escape while multiple protospacer mutations 
(up to four) outside the “seed” region did not affect CRISPR/Cas interference in E. coli. 
Consequently, they suggest that target recognition is initially based on a seven-
nucleotide protospacer “seed” region only then followed by full-length crRNA-
protospacer interaction (Semenova et al., 2011). Thus, similar to E. coli, CRISPR/Cas 
interference in S. solfataricus might be initiated by the recognition of a short sequence 
at the “up”-end (complementary to the 5’-end of spacer RNA) of the protospacer. This 
strategy may reflect a general characteristic of both archaeal and bacterial CRISPR/Cas 
systems facilitating a rapid detection of invading nucleic acid molecules. Additionally 
supportive is the work on a CRISPR associated protein complex isolated from 
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Pseudomonas aeruginosa showing high binding affinity when crRNA binds 
oligonucleotides matching the first 8 nucleotides from the 5’-end of RNA spacer 
sequence compared to weak affinity interaction between crRNA and nucleotides 
located outside the “seed” sequence (Wiedenheft et al., 2011). 
However, the indication that only a partial spacer sequence may already be sufficient 
for CRISPR interference raises the question why comparatively long DNA sequences 
are selected for spacer incorporation. One possible explanation would be the need for 
a minimal crRNA length to ensure stable complex formation of required Cas proteins 
during the interference process. Besides, the obtained data suggest that once the 
target has been recognized via sequence similarity at the 5’ end of spacer RNA the 
interference process also requires a minimal degree of base pairing at the crRNA 3’ 
proximal end. Lintner et al. achieved to isolate and characterize an archaeal CRISPR-
associated protein complex from S. solfataricus showing a helical structure of variable 
length that may result from progressive aggregation of various complex components 
during CRISPR/Cas interference (Lintner et al., 2011). Even though several mutations at 
the spacer RNA 3’ end are accepted without affecting CRISPR/Cas interference 
(compare construct 406-6Mdown) too many of them obviously weaken (compare 
constructs 406-9Mdown, -13Mdown, -14Mdown, 15Mdown) or even abolish (compare 
construct 406-18Mdown) interference. This might have been induced by resulting 
nucleic acid distortions preventing the correct positioning of processing Cas proteins 
despite target recognition in the first place. The existence of relatively “long” spacers 
exceeding the sequence information that is apparently sufficient for target recognition 
might additionally increase the probability to find additional cutting sites within 
protospacers, provided these are sequence specific. So far CRISPR/Cas-induced 
cleavage of invading DNA or RNA, respectively has only been found to occur sequence-
unspecific. Garneau et al were able to demonstrate CRISPR/Cas-mediated in vivo 
cutting of invading DNA in Streptococcus thermophilus indicating cleavage at 
consistent, sequence-unspecific positions within analyzed protospacers (Garneau et 
al., 2010). In vitro studies from Pyrococcus suggest that protospacer RNA instead of 
DNA underlies cleavage that occurs at a fixed 14nt distance from the 3’ end of crRNA 
(Hale et al., 2009). In contrast, the studies shown in this work might suggest that 
sequence-specific cleavage occurs: the unexpected low immune response (compared 
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to construct 406-14Mdown and -15Mdown) obtained from construct 406-13Mdown 
might imply that cutting happens at “AT”-sequences within the protospacer. 
Comparing these three viral vector constructs, 406-13Mdown exhibits one “AT” less 
than constructs 406-14Mdown and -15Mdown both of which contain 5 times “AT” 
(Figure 7) thus reducing the probability of actual cleavage within the protospacer 
sequence. Nevertheless, this hypothesis is highly speculative and needs to be verified 
by further experimental data. 
Various researchers suggested that mutations within so called PAM (protospacer 
adjecent motif) sequences may allow viruses to avoid CRISPR/Cas interference (Deveau 
et al; 2008; Mojica et al; 2009; Semenova et al; 2011). PAMs have primarily been 
mentioned by Mojica et al. and describe conserved nucleotide motifs that precede 
protospacer sequences (Mojica et al., 2009). Within this study substitutions at flanking 
positions upstream the ORF406-derived protospacer sequence have not been checked 
for their effect on CRISPR/Cas mediated viral defense. The tested protospacer mutants 
carry identical flanking sequences indicating that obtained transfection efficiencies 
have not been affected or even caused by mutations in protospacer proximal 
positions. Viral escape induced by mutations occurring at protospacer adjacent 
positions may rather be ascribed to growing complementarity between the repeat-
derived flanking sequence of spacer RNA and corresponding protospacer flanking 
regions than to absent PAMs. Those repeat-derived flanking sequences have been 
shown to play a crucial role in the avoidance of autoimmunity (Marraffini and 
Sontheimer 2010).  
As already reported by Manica et al (Manica et al., 2011) CRISPR/Cas based immunity 
of S. solfataricus was not dependent on target transcription. As the tested 
recombinant SSV1 variants in this study carried no promoter sequence in front of the 
protospacer containing gene this strongly implies that immunity resulted from CRISPR-
mediated degradation of invading viral DNA.  
Most notably, compared to E. coli the CRISPR/Cas complex in S. solfataricus seems to 
be remarkably tolerant towards mutations distinguishing target and spacer. An 
increased tolerance towards occurring protospacer mutations may reflect an 
adaptation to fast evolving target sequences providing the host organism a more 
flexible recognition of related invading elements without the need of incorporating 
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additional spacers. If the ability to successfully target an extraordinary broad spectrum 
of related viruses by a single spacer is restricted to the archaeal domain of life remains 
to be clarified by future research work.  
Regardless of applied viral protospacer mutants, the plaques showed no visible 
differences with respect to their turbidity. Comparing plaques that were e.g. obtained 
from constructs 406-6Mup and 406-6Mdown (Figure 14) varieties could only be seen 
in the sizes of their halos. Considering the experimental set-up of applied plaque tests, 
plaque formation results from a huge number of infections initially caused by 
propagation of an artificially introduced viral DNA molecule able to escape CRISPR/Cas 
interference. Hence, acquired transfection efficiency data derive from CRISPR/Cas 
activity upon the first infection event during electroporation. Once, the incoming viral 
DNA escapes the first CRISPR/Cas confrontation, replication results in the release of 
viral particles. Even though each subsequent infection event might be challenged by 
the CRISPR/Cas system the consistency in plaque turbidity suggests that most 
surrounding host cells face an infection. Probably due to the high dosage of viral 
particles, the CRISPR/Cas system cannot cope with infections anymore. The probability 
of interference might therefore primarily be represented by the number of resulting 
plaque forming units than by differences in plaque appearance. 
Varying levels of CRISPR/Cas immune response may allow for suppression and survival 
of viral populations that might under certain conditions be advantageous for the host 
organism. Reduced CRISPR/Cas-mediated interference might allow for controlled 
propagation of viral populations without substantial decrease of host density. Hence, 
viruses may be maintained over several generations within microbial populations 
allowing the conservation of foreign DNA even though the viral development is 
affected by the CRISPR/Cas system. As viral infection may result in the introduction of 
new genes that can under certain environmental conditions provide beneficial 
functions to the host (Madigan and Brock 2009), such strategy might additionally help 
to adapt to challenging environments and to invade new niches (reviewed in 
Roossinck, 2011). Besides, the maintenance of viral populations might also be 
advantageous when competing with other organisms not being resistant to the virus. 
However, to support these hypotheses, it needs to be verified if a viral population 
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suppressed to a certain extent by CRISPR/Cas could indeed be sustained over several 
generations of host populations.  
These hypotheses suggest that CRISPR/Cas strongly affects viral-host interactions 
determining besides other factors the intensity of new infections and the fitness of the 
host. Thus, the system might play a central role concerning developments and changes 
in microbial population structures and dynamics. However, future studies that help to 
better understand the system’s role within complex microbial communities are 
required to clarify the ecological relevance of the highly diverse CRISPR/Cas systems. 
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Appendix 
 
 
A) Abbreviations and definitions 
 
  
°C degree celcius 
µF microfarad 
µg microgram 
µl microlitre 
µm micromol 
Amp ampicillin 
ATP adenosine-5’-triphosphate 
bp’s base pairs 
c concentration 
Cas CRISPR-associated 
CRISPR clustered regularly interspaced short palindromic repeat 
crRNA CRISPR RNA 
ddH20 double-distilled water 
DNA desoxyribonucleic acid 
dNTP desoxynucleotide triphosphate 
ds double stranded 
e.g. for example 
fw forward 
g gram 
kb kilo bases 
l litre 
LB Luria Bertani 
LM DNA ladder mix 
M molar 
min minutes 
ml millilitre 
mM millimolar 
ng nanogram 
nm nanometer 
nt nucleotide 
OD optical density 
ORF open reading frame 
ori origin of replication 
PAM protospacer adjacent motif; nucleotide sequence flanking the 
protospacer 
PCR polymerase chain reaction 
PFU plaque forming unit 
protospacer nucleotide sequence in the phage genome corresponding to the 
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spacer 
RAMP repeat-associated mysterious protein 
RNA ribonucleic acid 
rpm runs per minute 
rw reverse 
Sp Spectinomycin 
sp53 spacer 53 
spacer small nucleotide sequence inserted between two repeats that 
corresponds to a foreign DNA sequence 
ss single stranded 
Taq Polymerase Thermus aquaticus polymerase 
u units 
V volt 
w/v weight per volume 
WOP without protospacer 
x times 
λ lamda 
Ω ohm 
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B) Zusammenfassung 
 
 
In natürlichen Ökosystemen sind Mikroorganismen stets einer enormen Anzahl und 
Vielfalt an Viren und anderen invasiven Nukleinsäuren ausgesetzt. Infolge dessen 
haben Mikroben verschiedene Abwehrstrategien entwickelt, um virale Infektionen 
bzw. den Eintritt von Fremd-DNA zu vermeiden. Clustered regularly interspaced short 
palindromic repeats (kurz: CRISPR) beschreiben bestimmte sich wiederholende DNA-
Abschnitte, die in vielen bakteriellen und den meisten archaealen Genomen auftreten 
und charakterisieren einen erst kürzlich bekannt gewordenen Abwehrmechanismus. 
Mittels CRISPR/Cas-Systemen erwerben Mikroorganismen Immunität gegen Infektion 
durch Viren und Eindringen anderer exogener Nukleinsäuren. Der CRISPR/Cas 
Mechanismus beruht auf der spezifischen Erkennung eindringender Fremd-DNA durch 
kleine, komplementäre RNAs, die als transkribierte Spacer-Sequenzen aus dem CRISPR 
locus als CRISPR RNAs (crRNAs) hervorgehen und einen so-genannten Protospacer 
erkennen, d.h. einen Sequenzabschnitt invasiver Nukleinsäuren, welcher Homologie zu 
einem Spacer aufweist. Im Gegenzug können Viren durch den Erwerb von Mutationen 
innerhalb ihrer Protospacer-Sequenz einer möglichen DNA Degradation entkommen 
und somit die erworbene Resistenz ihres Wirtsorganismus umgehen. 
Interessanterweise führt nicht jede Mutation, die innerhalb des Protospacers auftritt, 
zur Vermeidung von CRISPR/Cas-Interferenz. Bislang wurden die Auswirkungen von 
Protospacermutationen auf die CRISPR/Cas-basierende Interferenz vor allem in 
bakteriellen CRISPR/Cas Systemen untersucht. Um mehr über die Anforderungen für 
die Interaktion zwischen crRNA und Protospacer während der CRISPR/Cas-Interferenz 
in Archaea zu lernen, wurde der hyperthermophile Crenarchaeote Sulfolobus 
solfataricus und sein Virus SSV1 als Modellsystem in dieser Studie verwendet. Für die 
Arbeit wurden verschiedene Protospacermutanten des rekombinanten Virus SSV1 
hergestellt und anschließend in mehreren Transfektionsexperimenten untersucht. Die 
gentechnisch-veränderten Mutanten trugen eine steigende Anzahl an Mutationen an 
den jeweiligen Enden der Protospacer-Sequenz; d.h. im Ausmaß von sechs bis 18 
aufeinander folgenden Mutationen an beiden Protospacerenden. Trotz der 
eingeführten sechs Mutationen am „down“-Ende des Protospacers, welches dem 3‘-
Ende transkribierter Spacer RNA entspricht, vermittelte das S. solfataricus CRISPR/Cas 
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System beinahe 100% Immunität gegen das rekombinante Virus. Im Gegensatz dazu, 
wurde die Resistenz gegen das rekombinante Virus stark vermindert (um 75%), als 
sechs Mutationen am anderen Ende („up“-Ende) des Protospacers eingeführt wurden. 
Es konnten immer noch 50% CRISPR/Cas-basierende Immunität nachgewiesen werden, 
als 15 aufeinander folgende Mutationen am Protospacer „down“-Ende vorhanden 
waren. Erst die Einführung von 18 Mutationen am „down“-Ende führten zu einem 90 
%igen Rückgang der erworbenen Immunität. Ähnlich den erst kürzlich angestellten 
Beobachtungen in E. coli, erwies sich das CRISPR/Cas System als deutlich toleranter 
gegenüber Mutationen, die am „down“-Ende des Protospacers auftraten. Dies deutet 
darauf hin, dass CRISPR/Cas-Interferenz in S. solfataricus durch die Erkennung einer 
kurzen Sequenz am „up“-Ende des Protospacers initiiert wird. Verglichen mit dem 
bakteriellen System, schien die erforderliche Basenkomplementarität zwischen 
Zielsequenz und crRNA während der CRISPR/Cas-Interferenz jedoch sehr gering zu 
sein. Dies könnte auf eine Anpassung an sich rasch evolvierende Zielsequenzen 
hindeuten, was dem Wirtsorganismus eine flexiblere und effektivere Erkennung 
verwandter/nicht identer, invasiver Nukleinsäuren ermöglichen würde.  
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